Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era

Clinical Infectious Diseases(2021)10.1093/cid/ciab298Source: DataRank Database

Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era is a research paper published in Clinical Infectious Diseases (2021). On theSindex it has a DataRank of 0. It has been cited 88 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access88 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 9.14)OA: greenTopics (27)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Fareed Khawaja ORCID,Terri Lynn Shigle ORCID,Victoria Handy,Farnaz Foolad ORCID,Samuel L Aitken ORCID

Live enrichment

PubMed:33830182 PMC:PMC8528390 OpenAlex:https://openalex.org/W3148102859

National Institutes of Health

Grant: P30CA016672

National Cancer Institute

FWCI

9.14

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8528390

publisherhttp://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciab298/39785824/ciab298.pdf

publisherhttp://academic.oup.com/cid/article-pdf/73/8/1346/40786427/ciab298.pdf

journalhttps://doi.org/10.1093/cid/ciab298

Fields of Study

Cytomegalovirus and herpesvirus researchNeutropenia and Cancer InfectionsViral-associated cancers and disorders

MeSH Terms

AcetatesAntiviral AgentsCytomegalovirusHumansQuinazolinesRetrospective StudiesHematopoietic Stem Cell TransplantationTransplant Recipients

Keywords

MedicineHazard ratioInternal medicinePopulationConfidence intervalCytomegalovirusRefractory (planetary science)Retrospective cohort studyImmunologyViral diseaseHuman immunodeficiency virus (HIV)HerpesviridaeMortalityHematopoietic Cell TransplantLetermovirRefractory And Resistant Cytomegalovirus

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance

10.6084/m9.figshare.23707027.v1figshare

Additional file 1 of Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance

10.6084/m9.figshare.23707027figshare

Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era

FAIR Checklist

Authors (12)

Funding (2 grants)

Impact

Open Access

Topics

Linked Datasets (2)

Annotations (Europe PMC)